Trinity Biotech (TRIB) Other Operating Expenses (2009 - 2024)

Trinity Biotech has disclosed Other Operating Expenses across 16 years of filings, most recently posting -$1.8 million for Q4 2024.

• Other Operating Expenses for Q4 2024 came in at -$1.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.8 million (down 2.35% YoY), and the FY2025 annual result was $1.9 million, up 204.64% from the prior year.
• Other Operating Expenses came in at -$1.8 million for Q4 2024 at Trinity Biotech, down from $13000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $2.9 million in Q2 2021 to a low of -$1.8 million in Q4 2024.
• The 5-year median for Other Operating Expenses is $14000.0 (2020), against an average of $343800.0.
• Across the five-year window, Other Operating Expenses jumped 145200.0% in 2021 and tumbled 99.9% in 2022, its largest moves.
• Trinity Biotech's Other Operating Expenses stood at $1.8 million in 2020, then tumbled by 60.76% to $722000.0 in 2021, then tumbled by 52.77% to $341000.0 in 2022, then slumped by 79.47% to $70000.0 in 2023, then sank by 2712.86% to -$1.8 million in 2024.
• The last three Other Operating Expenses figures came in at -$1.8 million (Q4 2024), $13000.0 (Q2 2024), and $29000.0 (Q1 2024), per Business Quant data.